Meanwhile, neurofibromin 1 (NF1), a tumor suppressor gene that negatively regulates Ras signaling, has been found mutated in 10% of NSCLC cases and appears to be a predictive biomarker of response to immune checkpoint inhibitors [16,17,18]. The gene discussed is NF1; the disease is non-small cell lung carcinoma.